Midwest Bioprocessing Center Receives NIH Phase I SBIR Award for New Methods to Produce Important Deoxysugars

Media Contacts:

Elena Chaikin, Marketing Manager


Peoria, IL (June 16, 2022) – The Midwest Bioprocessing Center (MBC), a leading producer of bio-based chemicals for human health and nutrition, announced that it has been awarded a $217,000 grant from the National Institutes of Health to develop new technology to produce important deoxysugars for pharmaceutical drug discovery applications.

These specialized sugars are often important structural components of bioactive natural products, such as antibiotics and anticancer therapeutics.  Although they are of increasing interest to drug discovery researchers who want to test the effect of altering sugar substituents on the therapeutics that they are developing, deoxysugars are often difficult or impossible to synthesize using current chemical technologies.

“Our goal in this project is to support researchers that are working on the development of new therapeutics by allowing them to test the effects of different deoxysugars they can’t currently make or buy,” said Dr. Robert Turner, Principal Investigator on the Project. “We think that these important molecules can have a profound effect on developing new anti-infective and anticancer therapeutics.”

The Company plans on selling the resulting deoxysugars as part of its zuCarb™ line of rare and modified sugars for research applications.  In addition to selling products from its growing catalog, MBC also synthesizes custom chemicals and carries out collaborative research using its proprietary technology platform.

Visit the Company’s website to learn about the Midwest Bioprocessing Center www.mwbioprocessing.com or its zuCarb™ line of rare sugars (www.mwbioprocessing.com/zuCarb).  Inquiries can be sent to products@mwbioprocessing.com.

About the Midwest Bioprocessing Center, LLC.

The Midwest Bioprocessing Center is a start-up biotechnology company formed in 2019 to bring important new bio-based technologies to market for human health and nutrition.  The Midwest Bioprocessing Center has facilities to carry out enzyme biocatalysis, fermentation, chemical synthesis, and product purification for its own use and on behalf of its clients.  MBC’s proprietary brands include the zuCarb™ Rare sugar platform, the ThermoCat™ stable biocatalysts, and the iActive FeruliShield™ Feruloyl Glycerides for Personal Care.  The Company’s proprietary enzyme and fermentation technology platform allows production and modification of carbohydrates, glycochemicals, and lipids that would otherwise be impractical or impossible to make.  The Midwest Bioprocessing Center is located in Peoria, IL and housed in the PeoriaNEXT Innovation Center.  For more information please contact:


801 W Main St

Peoria, IL 61606

Tel: (630) 230-0349


Share this post:

This site uses cookies. By continuing to use this website, you agree to their use. Privacy Policy

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.